This department is offering a grant to research the effectiveness and implementation of interventions for HIV+ individuals with alcohol use problems. The focus is on utilizing technology and biomarkers to improve implementation strategies and comparative effectiveness research. The goal is to enhance clinical decision-making and provide evidence-based services for HIV+ individuals, considering patient and provider characteristics, as well as organizational and structural factors. Two major topics are included in the solicitation: comparative effectiveness research on early detection and treatment responses, and testing implementation approaches to improve interventions’ uptake and reduce HIV disease transmission.
Opportunity ID: 299793
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAS-18-557 |
| Funding Opportunity Title: | Research on Comparative Effectiveness and Implementation of HIV/AIDS and Alcohol Interventions (R01 – Clinical Trials Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.273 — Alcohol Research Programs |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jan 02, 2018 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | May 07, 2020 |
| Current Closing Date for Applications: | May 07, 2020 |
| Archive Date: | Jun 12, 2020 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $500,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | County governments Public housing authorities/Indian housing authorities Small businesses State governments Native American tribal governments (Federally recognized) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) Special district governments Public and State controlled institutions of higher education Private institutions of higher education City or township governments Native American tribal organizations (other than Federally recognized tribal governments) For profit organizations other than small businesses Independent school districts |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | HIV+ alcohol users remain at high risk for medication non-adherence and rapid disease progression, medication toxicities, organ failure, and poor viremic control, leading to increased risk of transmission and premature death. Recent advances in technology and biomedical science (e.g., new pharmacological agents, alcohol and inflammation biomarkers, internet and mobile technology) open new opportunities for strengthening the quality of HIV/alcohol-related implementation research through utilization of novel technology and biomarkers. This initiative seeks to advance knowledge on implementation and comparative effectiveness of alcohol-focused interventions among HIV+ individuals. Multiple factors need to be investigated, including potentially important patient and provider characteristics, and the organizational, financial, and structural factors that facilitate or inhibit the delivery of evidence-based services for HIV+ individuals with a range of severity of alcohol use problems. The overall goal is to inform clinical decision-making to implement effective interventions that will improve prevention, care, and outcomes across the continuum of HIV and alcohol problem severity and patterns of alcohol use. This solicitation is divided into two major topics. An application may choose to address one or both. These topics include: 1) comparative effectiveness research focused on understanding factors related to early detection, patient engagement and retention in appropriate alcohol and HIV care, and achieving and maintaining optimal treatment responses in diverse settings, and 2) modeling and testing alternative implementation approaches to improve uptake and scaling-up of effective interventions and reduce HIV disease transmission and progression. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAS-18-557.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-E | Use for due dates on or before May 24, 2020 | PKG00237380 | Jan 05, 2018 | May 24, 2020 | View | |
| FORMS-F | Use for due dates on or after May 25, 2020 | PKG00259224 | Jan 05, 2018 | May 07, 2020 | View |
Package 1
Mandatory forms
299793 RR_SF424_2_0-2.0.pdf
299793 PHS398_CoverPageSupplement_4_0-4.0.pdf
299793 RR_OtherProjectInfo_1_4-1.4.pdf
299793 PerformanceSite_2_0-2.0.pdf
299793 RR_KeyPersonExpanded_2_0-2.0.pdf
299793 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
299793 RR_Budget_1_4-1.4.pdf
299793 RR_SubawardBudget30_1_4-1.4.pdf
299793 PHS398_ModularBudget_1_2-1.2.pdf
299793 PHS_AssignmentRequestForm_2_0-2.0.pdf
Package 2
Mandatory forms
299793 RR_SF424_2_0-2.0.pdf
299793 PHS398_CoverPageSupplement_5_0-5.0.pdf
299793 RR_OtherProjectInfo_1_4-1.4.pdf
299793 PerformanceSite_2_0-2.0.pdf
299793 RR_KeyPersonExpanded_2_0-2.0.pdf
299793 PHS398_ResearchPlan_4_0-4.0.pdf
299793 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
299793 RR_Budget_1_4-1.4.pdf
299793 RR_SubawardBudget30_1_4-1.4.pdf
299793 PHS398_ModularBudget_1_2-1.2.pdf
299793 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
